Luhmann Scott J, Sucato Daniel J, Bacharier Leonard, Ellis Alysa, Woerz Cyndi
Department of Orthopaedics, Washington University School of Medicine, St Louis, MO 63110, USA.
J Pediatr Orthop. 2013 Jul-Aug;33(5):e58-60. doi: 10.1097/BPO.0b013e3182857d88.
FloSeal and SurgiFlo Hemostatic Matrices are commonly used in surgical procedures to promote coagulation and minimize blood loss. They are composed of bovine and porcine gelatin matrix, respectively, that can be injected into pedicles to stop osseous bleeding during pedicle screw insertion.
This report details 2 pediatric spinal deformity reconstructive surgery patients who experienced intraoperative cardiovascular events after the intraosseous administration of animal-derived gelatin.
Case #1 is an 11-year-old female with adolescent idiopathic scoliosis who was undergoing routine posterior spinal instrumentation and fusion. During placement of the fourth pedicle screw, the patient developed profound hypotension, tachycardia, and elevated airway pressures requiring intravenous epinephrine and phenylephrine for hemodynamic support. Surgery was aborted. Postoperative work-up demonstrated a positive ImmunoCAP study for bovine gelatin. Surgery was repeated 1 week later, without the use of FloSeal, and no episodes of hemodynamic instability. Case #2 was a 9-year-old female with juvenile idiopathic scoliosis who was undergoing a growing spine construct. As in Case #1, SurgiFlo was placed into 2 pedicle tracts after which there was profound hypotension, tachycardia, and elevated airway pressures. Resuscitative efforts included intravenous atropine and epinephrine with resolution. Surgery was aborted. Surgery was repeated 2 weeks later, without the use of SurgiFlo, with no episodes of hemodynamic instability.
Given that the patient's symptoms were classic for anaphylaxis, and that the timing of the anaphylaxis immediately followed the administration of FloSeal and SurgiFlo we believe that FloSeal and SurgiFlo were the causes of the reactions. These are the first known reported cases of intraoperative anaphylaxis associated with FloSeal and SurgiFlo. On the basis of our experience, in order to avoid intraoperative cardiovascular events, we obtain preoperative ImmunoCAP testing and eliciting a thorough preoperative history about bovine-derived and porcine-derived gelatin products.
FloSeal和SurgiFlo止血基质常用于外科手术中促进凝血并减少失血。它们分别由牛和猪明胶基质组成,可注入椎弓根以在椎弓根螺钉植入过程中阻止骨质出血。
本报告详细介绍了2例小儿脊柱畸形重建手术患者,他们在骨内注射动物源性明胶后发生了术中心血管事件。
病例1是一名11岁患有青少年特发性脊柱侧凸的女性,正在接受常规后路脊柱内固定和融合手术。在置入第四枚椎弓根螺钉时,患者出现严重低血压、心动过速和气道压力升高,需要静脉注射肾上腺素和去氧肾上腺素进行血流动力学支持。手术中止。术后检查显示牛明胶免疫酶联吸附测定(ImmunoCAP)研究呈阳性。1周后在未使用FloSeal的情况下重复手术,未出现血流动力学不稳定情况。病例2是一名9岁患有幼年特发性脊柱侧凸的女性,正在进行生长性脊柱构建手术。与病例1一样,在将SurgiFlo置入2个椎弓根通道后,出现严重低血压、心动过速和气道压力升高。复苏措施包括静脉注射阿托品和肾上腺素,症状得到缓解。手术中止。2周后在未使用SurgiFlo的情况下重复手术,未出现血流动力学不稳定情况。
鉴于患者的症状是过敏反应的典型表现,且过敏反应发生时间紧接FloSeal和SurgiFlo给药之后,我们认为FloSeal和SurgiFlo是反应的原因。这些是已知的首例与FloSeal和SurgiFlo相关的术中过敏反应报告病例。根据我们的经验,为避免术中心血管事件,我们进行术前免疫酶联吸附测定(ImmunoCAP)检测,并详细询问术前关于牛源性和猪源性明胶产品的病史。